Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Xavier Fung Miriam Hjertnes Thought, mood and anxiety disorder Neurotransmitter and messaging centre disturbed Affects ones perception of reality 12000 – 16000 in Norway 600 – 800 per year approxiamately Rough estimate 10% suicide rate 1) 2) 3) Paranoid type – suspicions, paranoia and relationship difficulties Disorganized type – Disorder and Flat effect. Occurs earlier and gradually, disorganized speech and behavior, trouble taking care of themselves Catatonic type – Disturbance in movement and decreased motor activity Positive symptoms – distort and exaggerated sights, sounds, thoughts and behavior Beliefs, hallucinations, bizzare behavior and disorganized sppech, thoughts and movement Negative symptoms – lack of motion or interest and flat effect, personal hygeine Alogia and lack of speech, Avoltion and Anhedonia, posturing 1) 2) Genetic factors – only influencing First degree relative 10% General population 1% 60% no family history Environmental factors – trigger High levels of stress examples Cortisol concentration increase • 40 – 50% Schizophrenics have abnormalities • Enlarged brain ventricles Abnormalties: temporal lobe, hippocampus, amygdala, frontal lobe Two main neurotransmitters– dopamine, glutamate PET scans - Regions of the brain that are activated when a person performs a memory task. Movement and thoughts, reward, feelings and pleasure High levels = psychotic and paranoid thinking Larger amount of dopamine receptors in schizophrenics Overactive dopamine system Amphetamine induces dopamine and symptoms of schizophrenia Learning and formation and encoding of memory Inhibition of glutamate receptors cause symptoms of schizophrenia e.g. PCP and ketamine High levels of glutamate inhibitors thought disorders Glutamate receptors located throughout the brain widespread cortical dysfunction Located in brain circuits regulating dopamine release dopamine concentration is linked to glutamate activity 25% recovery Medication + psychosocial treatment + regular examination Exercise of Cognitive and Social skills Men diagnosed earlier and tend to have have greater social dysfunction Encouragement and help controlling of symptoms Learning required social skills Supporting goals and activities Regaining confidence – ordinary tasks Group therapy + medication Family therapy reduces relapse rate below 10% Antidepressant Antipsychotic Anti-anxiety Challenges -cease taking medication 1) 2) Normalise biochemical imbalances, reduce relapse Two types Traditional Antipsychotics – hallucinations, delusions and confusions – block dopamine receptors New antipsychotics – may work on both serotonin and deopamine receptors, fewer side effects and more effective Atypical antipsychotics- Stabalization of mood, decreases frequency and intensity of mood swings – side effects Used as priority medication 1% of world Roughly 1.5million will be diagnosed every year Prevlance rate : 1.1% of the population over 18 7.2 people out of 1000 51 million worldwide at any one time 30% Graph showing recovery of Schizophrenics 25% 20% 15% 10% 5% 0% Complete Recovery Much Improved Hospitalized improved but requires support Dead http://www.humanillnesses.com/Behavioral-Health-ObSea/Schizophrenia.html#b http://www.jamesdisabilitylaw.com/schizophrenia.htm http://www.who.int/mental_health/management/schizophrenia/en/ http://www.schizophrenia.com/szfacts.htm 5 http://www.physio-pedia.com/Schizophrenia http://www.fhi.no/eway/default.aspx?pid=233&trg=MainLeft_5565 &MainArea_5661=5565:0:15,2343:1:0:0:::0:0&MainLeft_5565=5544 :61140::1:5569:9:::0:0 http://nhi.no/sykdommer/psykisk-helse/schizofreni/schizofrenioversikt-3090.html?page=4 http://www.medicinenet.com/schizophrenia/page4.htm#how_is_sch izophrenia_diagnosed